To me, the overall tone of their communications over the last 1-2+ months is that IDE approval is a given and thus they are thinking and acting as if beyond that point.
I believe that while this process is unfolding, they have the time to focus on IsoPet and more clinics, which is what they just let on to shareholders a few days ago.
They sure as hell ain't sitting on their hands here. I think there is much more going on then they let on. Every, and I mean EVERY time they eventually put out info after
what shareholders perceive is waaay too long to wait, shareholders are like, "ohhhhh THAT'S what they've been doing." And everything is OK.
Market Data 
Markets 
AI
